David Shaw’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-7,700
Closed -$558K – 4448
2025
Q1
$558K Buy
+7,700
New +$551K ﹤0.01% 3446
2024
Q3
– Sell
-9,600
Closed -$887K – 4627
2024
Q2
$887K Buy
+9,600
New +$850K ﹤0.01% 3269
2021
Q1
– Sell
-102,900
Closed -$9.39M – 4169
2020
Q4
$9.39M Hold
102,900
– – 0.01% 1421
2020
Q3
$8.21M Sell
102,900
-30,000
-23% -$2.34M 0.01% 1370
2020
Q2
$9.18M Hold
132,900
– – 0.01% 1236
2020
Q1
$8.36M Sell
132,900
-17,700
-12% -$1.28M 0.01% 1099
2019
Q4
$11.7M Buy
150,600
+10,800
+8% +$843K 0.01% 1105
2019
Q3
$10.2M Buy
139,800
+60,000
+75% +$4.21M 0.01% 1143
2019
Q2
$4.91M Hold
79,800
– – 0.01% 1601
2019
Q1
$5.09M Buy
+79,800
New +$4.55M 0.01% 1541
2018
Q1
– Sell
-30,000
Closed -$1.13M – 3573
2017
Q4
$1.13M Hold
30,000
– – ﹤0.01% 2509
2017
Q3
$1.09M Hold
30,000
– – ﹤0.01% 2438
2017
Q2
$1.18M Hold
30,000
– – ﹤0.01% 2306
2017
Q1
$941K Hold
30,000
– – ﹤0.01% 2333
2016
Q4
$937K Hold
30,000
– – ﹤0.01% 2498
2016
Q3
$1.21M Buy
+30,000
New +$1.13M ﹤0.01% 2281
2016
Q1
– Sell
-240,000
Closed -$6.32M – 3525
2015
Q4
$6.32M Hold
240,000
– – 0.01% 1249
2015
Q3
$5.69M Hold
240,000
– – 0.01% 1310
2015
Q2
$5.7M Hold
240,000
– – 0.01% 1364
2015
Q1
$5.7M Hold
240,000
– – 0.01% 1295
2014
Q4
$5.1M Buy
240,000
+180,000
+300% +$3.62M 0.01% 1554
2014
Q3
$1.02M Buy
+60,000
New +$947K ﹤0.01% 2795
2013
Q4
– Sell
-37,200
Closed -$432K – 4522
2013
Q3
$432K Buy
+37,200
New +$435K ﹤0.01% 3675

Other funds holding EW

David Shaw's EW Position: Q3 2026 in Review

David Shaw opened a new position in Edwards Lifesciences (EW) in Q3 2026: 4,045 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #4427 among its holdings. This is a return to the name: David Shaw previously reported a position in EW as recently as Q4 2025.

David Shaw first reported a position in EW in Q2 2013 and has held it in 46 quarters since. The position peaked at $251M in Q1 2023. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • David Shaw held 4,045 shares of Edwards Lifesciences worth $349K as of Q3 2026.
  • Edwards Lifesciences was a new David Shaw position in Q3 2026.
  • Edwards Lifesciences made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4427 holding.
  • David Shaw first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 46 quarters since.
  • David Shaw's Edwards Lifesciences position peaked at $251M in Q1 2023.
  • 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.